1 Breaking News found.
  • Merck’s COVID-19 Antiviral Drug Doesn’t Reduce Hospitalization Or Death In High-Risk Vaccinated People: Study
    by enderworld
    Dec 28, 2022
    Health

    The COVID-19 antiviral drug Molnupiravir helps speed up recovery from the virus but does not reduce the hospitalization or death rate in higher-risk vaccinated adults, a new study has found. Molnupiravir, from Ridgeback Biotherapeutics and Merck & Co. is used to treat mild to moderate COVID-19 and c...

    0 0 0 211 0/5
    Read More